Skip to search formSkip to main contentSkip to account menu

ursodeoxycholyl lysophosphatidylethanolamide

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

LysophospholipidsUrsodiol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The Bile Acid-Phospholipid Conjugate Ursodeoxycholyl-Lysophosphatidylethanolamide (UDCA-LPE) Disintegrates the Lipid Backbone of Raft Plasma Membrane Domains by the Removal of the Membrane…
The bile acid-phospholipid conjugate ursodeoxycholyl-lysophosphatidylethanolamide (UDCA-LPE) was shown to have anti-inflammatory… 
2015
2015
Ursodeoxycholyl Lysophosphatidylethanolamide Protects Against Hepatic Ischemia and Reperfusion Injury in Mice
ABSTRACT The ischemia and reperfusion (I/R) injury that occurs during liver transplantation causes severe complications leading… 
2015
2015
Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins
An increase of toxic bile acids such as glycochenodeoxycholic acid occurs during warm ischemia reperfusion causing cholestasis… 
2015
2015
Charakterisierung antiinflammatorischer Eigenschaften von Ursodeoxycholyl-Lysophosphatidylethanolamid in Endotoxin-vermittelten entzündlichen Lebererkrankungen
2013
2013
Evaluation for oral use of Ursodeoxycholyl Lysophosphatidylethanolamide (UDCA-LPE): Effective resorption of sodium salt UDCA-LPE
2011
2011
Anti-fibrogene Wirkung des Gallensäure-Phospholipid-Konjugates Ursodeoxycholyl Lysophosphatidylethanolamid durch Inhibition des TGFβ1/Smad-Signalweges
2010
2010
Wirksamkeit von Ursodeoxycholyl Lysophosphatidylethanolamid in diätetischen Mausmodellen der nicht-alkoholischen Fettlebererkrankung (NAFLD)
2009
2009
Ursodeoxycholyl-Lysophosphatidylethanolamid (UDCA-LPE) inhibiert TNFα-vermittelte Apoptose und Inflammation in Leberzellen durch Reduktion von Lysophoshatidylcholin und Inhibition pro…
2009
2009
Hepatoprotektive Wirkung von Ursodeoxycholyl-Lysophosphatidylethanolamid (UDCA-LPE) in einem in vivo Modell für akute Endotoxin-vermittelte Hepatotoxizität
Einleitung: D-Galaktosamin/Lipopolysaccharid (Gal/LPS) verursacht in der Maus eine akute, Endotoxin-vermittelte Hepatitis; einer… 
1990
1990
Prevention of ursodeoxycholate hepatotoxicity in the rabbit by conjugation with N‐methyl amino acids
The effect of dietary administration of four different amino acid (N‐acyl) conjugates of ursodeoxycholic acid on biliary bile… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)